rTMS for ADHD

(FAST-ADHD Trial)

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Calgary

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial tests if a treatment using magnetic pulses to stimulate the brain can reduce ADHD symptoms in children and adolescents. It targets those who may not respond well to traditional treatments. The magnetic pulses aim to improve brain function related to attention and behavior. This non-invasive brain stimulation tool has potential for broad application in individuals with neuropsychiatric conditions, including ADHD.

Eligibility Criteria

This trial is for children aged 8-16 with ADHD, an IQ over 80, and stable on current medication for at least 3 months. They must speak English to give consent. It's not suitable for those with autism, bipolar disorder, psychosis, mania or a history of certain brain treatments or metal implants.

Inclusion Criteria

I have been diagnosed with ADHD.

I am between 8 and 16 years old.

You have an IQ higher than 80.

Exclusion Criteria

I have had electroconvulsive therapy or vagus nerve stimulation before.

You have metal implants in your body that would make it difficult to do TMS or MRI.

I have been diagnosed with Autism Spectrum Disorder.

Treatment Details

Interventions

• rTMS (Non-invasive Brain Stimulation)

Trial Overview The study is examining the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in reducing ADHD symptoms compared to standard treatment options.

Participant Groups

Group I: Active rTMS Experimental Treatment 1 Intervention

Active repetitive TMS

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials

827

Recruited

902,000+